1. Home
  2. WVE vs BRZE Comparison

WVE vs BRZE Comparison

Compare WVE & BRZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.19

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Braze Inc.

BRZE

Braze Inc.

HOLD

Current Price

$28.12

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
BRZE
Founded
2012
2011
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
WVE
BRZE
Price
$6.19
$28.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
26
Target Price
$29.81
$37.88
AVG Volume (30 Days)
3.9M
3.3M
Earning Date
04-28-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
$738,182,000.00
Revenue This Year
N/A
$22.69
Revenue Next Year
$85.67
$16.93
P/E Ratio
N/A
N/A
Revenue Growth
149.43
24.40
52 Week Low
$5.02
$15.26
52 Week High
$21.73
$37.67

Technical Indicators

Market Signals
Indicator
WVE
BRZE
Relative Strength Index (RSI) 35.45 69.12
Support Level $6.02 $25.94
Resistance Level $7.65 $29.28
Average True Range (ATR) 0.35 1.62
MACD 0.05 0.56
Stochastic Oscillator 15.04 94.47

Price Performance

Historical Comparison
WVE
BRZE

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About BRZE Braze Inc.

Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates majority of its revenue from the United States.

Share on Social Networks: